Forum Replies Created
-
Replies
-
Thank you for your response. Yes, most definitely. Good communication is a major factor in any study/team dynamics.
An important factor in stakeholder retention is continuous communication even when study activities are in a maintenance phase. Also, ensure that your study team (including Medical Lead) are involved in this communication or schedule dialog.
I enjoyed reading your post. From my years of experience working hand in hand with the CMO for the study, I have found that when the CMO is engaged in conversation with the participating PIs and site staff, the study seems to run so much smoother and generally also has a positive influence on the sites’ performance and rate of enrollment. Communication between all parties is a major key to success.
Thank you for sharing your experience! I always find it so interesting how different people work to “break down those silos”. Be it academia or the pharmaceutical/biotech industry, individuals become comfortable in their roles and sometimes temporarily forget that there are other individual involved in the project. I like how you worked to identify their roles in the team, but then also made them realize that even though you have a role, you are still part of a team. Congratulations on your team management accomplishment.
To ensure the community stakeholders understand the objectives of the trial which will be run in their region, it is imperative to begin those discussions earlier in the development process. For my current trial these discussions did occur, but not in the early development stage of the protocol. In the future I will ensure that these discussions start earlier in order to achieve transparency between the team members and stakeholders, as well as to reduce the amount of future protocol amendments.
Two situations in a team setting that bother me more than anything are miscommunication and team members that work in silos. The only way to ensure that leadership and your team members have a common understanding of stakeholder engagement and its value is to review it with the team at the beginning of your project. Have them help you to identify the stakeholders and review how best to work with each of those stakeholders. Also, review how each of the functions represented can work together in this team dynamics. When I start up a new trial one of the first things I do is hold a team meeting to ensure everyone understands from which other functional platforms the team members are, what their role is on the team and how each of their roles affect the others.
Hi Everyone, I am a Global Trial Leader for a pharmaceutical company working on HIV clinical trials and located in the United States in Pennsylvania. I was recommended to take this course by my manager. I would like to get the most out of learning the ins and outs of GPP and how I can use it in my role.
